Skip to main content
Log in

Interference of hepatitis B virus with cellular signaling

  • Published:
Virologica Sinica

Abstract

The presence of hepatitis B virus (HBV) proteins leads to changes in the cellular gene expression. As a consequence, the cellular signaling processes are influenced by the actions of HBV proteins. It has been shown that HBV nucleocapsid protein and the amino-terminal part of polymerase termed as terminal protein (TP) could inhibit interferon signaling. Further, the global gene expression profiles differ in hepatoma cells with and without HBV gene expression and replication. The expression of interferon (IFN) stimulated genes (ISGs) was differently regulated in cells with HBV replication and could be modulated by antiviral treatments. The HBV TP has been found to modulate the ISG expression and enhance the HBV replication. The modulation of the cellular signaling processes by HBV may have significant implications for pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bouchard M J, Schneider R J. 2004. The enigmatic X gene of hepatitis B virus. J Virol, 78: 12725–12734.

    Article  PubMed  CAS  Google Scholar 

  2. Christen V, Duong F, Bernsmeier C, et al. 2007. Inhibition of alpha interferon signaling by hepatitis B virus. J Virol, 81(1): 159–165.

    Article  PubMed  CAS  Google Scholar 

  3. Dienes H P, Hess G, Wöorsdörfer M, et al. 1991. Ultrastructural localization of interferon-producing cells in the livers of patients with chronic hepatitis B. Hepatology, 13(2): 321–326.

    PubMed  CAS  Google Scholar 

  4. Duong F H, Christen V, Berke J M, et al. 2005. Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1. J Virol, 79(24): 15342–15350.

    Article  PubMed  CAS  Google Scholar 

  5. Duong F H, Filipowicz M, Tripodi M, et al. 2004. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology, 126(1): 263–277.

    Article  PubMed  CAS  Google Scholar 

  6. Fang J W, Wu P C, Lai C L, et al. 1994. Hepatic expression of interferon-alpha in chronic hepatitis B virus infection. Dig Dis Sci, 39(9): 2014–2021.

    Article  PubMed  CAS  Google Scholar 

  7. Fern’andez M, Quiroga J A, Carreño V. 2003. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J Gen Virol, 84(Pt 8): 2073–2082.

    Article  CAS  Google Scholar 

  8. Foster G R, Ackrill A M, Goldin R D, et al. 1991. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci USA, 88(7): 2888–2892. Erratum in: Proc Natl Acad Sci USA, 92 (8): 3632.

    Article  PubMed  CAS  Google Scholar 

  9. Foster G R, Goldin R D, Hay A, et al. 1993. Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy. Hepatology, 17(5): 757–762.

    PubMed  CAS  Google Scholar 

  10. Ganem D, Pollack J R, Tavis J. 1994. Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect Agents Dis, 3: 85–93.

    PubMed  CAS  Google Scholar 

  11. Gordien E, Rosmorduc O, Peltekian C, et al. 2001. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol, 75(6): 2684–2691.

    Article  PubMed  CAS  Google Scholar 

  12. Guan S H, Lu M, Grünewald P, et al. 2007. Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J Gastroenterol, 13(2): 228–235.

    PubMed  CAS  Google Scholar 

  13. Guo Y, Guo H, Zhang L, et al. 2005. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol, 79(22): 14392–14403.

    Article  PubMed  CAS  Google Scholar 

  14. Haller O, Stertz S, Kochs G. 2007. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect, 9: 1636–1643.

    Article  PubMed  CAS  Google Scholar 

  15. Janssen H L, van Zonneveld M, Senturk H, et al. 2005. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet, 365: 123–129.

    Article  PubMed  CAS  Google Scholar 

  16. Jilbert A R, Burrell C J, Gowans E J, et al. 1986. Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue. Hepatology, 6(5): 957–961.

    Article  PubMed  CAS  Google Scholar 

  17. Lau G K, Piratvisuth T, Luo K X, et al. 2005. Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med, 352: 2682–2695.

    Article  PubMed  CAS  Google Scholar 

  18. Locarnini S, Shaw T, Dean J, et al. 2005. Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J Clin Virol, 32(2): 113–121.

    Article  PubMed  CAS  Google Scholar 

  19. Nouri-Aria K T, Arnold J, Davison F, et al. 1991. Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection. Hepatology, 13(6): 1029–1034. Erratum in: Hepatology, 14 (6): 1308.

    Article  PubMed  CAS  Google Scholar 

  20. Nakanishi F, Ohkawa K, Ishida H, et al. 2005. Alteration in gene expression profile by full-length hepatitis B virus genome. Intervirology, 48(2–3): 77–83.

    Article  PubMed  CAS  Google Scholar 

  21. Rang A, Bruns M, Heise T, Will H. 2002. Antiviral activity of interferon-alpha against hepatitis B virus can be studied in non-hepatic cells and Is independent of MxA. J Biol Chem, 277(10): 7645–7647.

    Article  PubMed  CAS  Google Scholar 

  22. Rosmorduc O, Sirma H, Soussan P, et al. 1999. Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein. J Gen Virol, 80(Pt 5): 1253–1262.

    PubMed  CAS  Google Scholar 

  23. Twu J S, Lee C H, Lin P M, et al. 1988. Hepatitis B virus suppresses expression of human beta-interferon. Proc Natl Acad Sci USA, 85(1): 252–256.

    Article  PubMed  CAS  Google Scholar 

  24. Twu J S, Schloemer R H. 1989. Transcription of the human beta interferon gene is inhibited by hepatitis B virus. J Virol, 63(7): 3065–3071.

    PubMed  CAS  Google Scholar 

  25. Wang G H, Seeger C. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell, 71(4): 663–670.

    Article  PubMed  CAS  Google Scholar 

  26. Wang G H, Seeger C. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol, 67(11): 6507–6512.

    PubMed  CAS  Google Scholar 

  27. Wang X, Yuan Z H, Zheng L J, et al. 2004. Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-alpha. World J Gastroenterol, 10(12): 1740–1745.

    PubMed  CAS  Google Scholar 

  28. Whitten T M, Quets A T, Schloemer R H. 1991. Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J Virol, 65(9): 4699–4704.

    PubMed  CAS  Google Scholar 

  29. Wu M, Xu Y, Lin S, et al. 2007. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J Gen Virol, 88(Pt 12): 3260–3269.

    Article  PubMed  CAS  Google Scholar 

  30. Yang J, Bo X C, Yao J, et al. 2005. Differentially expressed cellular genes following HBV: potential targets of anti-HBV drugs? J Viral Hepat, 12(4): 357–363.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Meng-ji Lu.

Additional information

Foundation items: Deutsche Forschungsgemeinschaft (Lu 669/2-1, GRK1045/1, and Lu 669/5-1); Joint program of Deutscher Akademischer Austauschdienst and Chinese Academy of Science.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, Y., She, Cw., Zhang, Xy. et al. Interference of hepatitis B virus with cellular signaling. Virol. Sin. 23, 100–106 (2008). https://doi.org/10.1007/s12250-008-2940-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-008-2940-0

Key words

CLC number

Navigation